GSE208781 GSE208784 dopamine 0 v 1 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE208781_GSE208784_dopamine_0_v_1_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE208781_GSE208784_dopamine_0_v_1_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE208781_GSE208784_dopamine_0_v_1_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE208781_GSE208784_dopamine_0_v_1_human_up.

Results found

Linked to

 

Label

Description

 

Gene

NBPF member 26

Gene

small integral membrane protein 44

Gene

long intergenic non-protein coding RNA 1128

Gene

negative regulator of antiviral response

Gene

neighbor of BRCA1 lncRNA 2

Gene

MT-ND4 pseudogene 12

Gene

NINJ2 antisense RNA 1

Gene

long intergenic non-protein coding RNA 886

Gene

CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1

Gene

B3GALT5 antisense RNA 1


  • Gene

    small integral membrane protein 44


  • Gene

    long intergenic non-protein coding RNA 1128


  • Gene

    negative regulator of antiviral response


  • Gene

    neighbor of BRCA1 lncRNA 2


  • Gene

    MT-ND4 pseudogene 12


  • Gene

    NINJ2 antisense RNA 1


  • Gene

    long intergenic non-protein coding RNA 886


  • Gene

    CDKN2B and CDKN2A antisense cis and trans regulatory RNA 1


  • Gene

    B3GALT5 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.